GHI Genomic Health Inc. / uRS / Eastern Cooperative Oncology Group / Cox / Quality Assurance Program Pty Ltd / Genomic Health Inc. / /
Continent
Europe / South America / /
Country
United States / Canada / Australia / /
Currency
pence / Rs / /
Event
FDA Phase / /
Facility
Medical Research Council NICE National Institute / AIHW Australian Institute of Health / Genomic laboratory / Genomic Health laboratory / College of American Pathologists / National Cancer Institute / CAP College / Genomic Health Inc. laboratory / Royal College of Pathologists / /
IndustryTerm
appropriate technology / Real time / vascular systems / prognostic algorithm / real-time reverse-transcriptase polymerase chain reaction / healthcare / healthcare resource / diagnostic medical devices / ultrasound imaging / therapy for breast cancer / treatment of breast cancer / reproducible technology / healthcare system perspective / healthcare resources / literature search / treatment algorithm / /
MarketIndex
set 250 / /
MedicalCondition
invasive tumours / rat sarcoma / primary breast cancer / HER2 negative breast cancer / metastasis / early breast cancer / node positive disease / ER-positive disease / insufficient invasive tumor / hormone receptor-positive breast cancer / tumour to enable breast / metastatic breast cancer / injury / early stage breast cancer / illness / breast cancer / mid-range Recurrence Score disease / breast tumours / breast tumour / common cancer / cancer / Tumors / total disease / disease / Malignant Tumours uRS / node negative breast cancer / tumour / ER+ breast cancer / invasive breast cancers / invasive carcinoma / invasive breast cancer / distant metastases / B-cell lymphoma / tumours / breast cancer stage I-II / /
National Cancer Institute / AIHW Australian Institute of Health / Royal College of Pathologists of Australasia / ESMO European Society for Medical / College of American Pathologists / Bioanalysts AACR American Association / Ovarian Cancer Centre NCCN National Comprehensive Cancer Network NHMRC National Health and Medical Research Council NICE National Institute for Health / Therapeutic Goods Administration / American Joint Committee on Breast Cancer TNM / National Association of Testing Authorities / Medicare / American Joint Committee on Cancer Staging / NATA National Association / Medical Service / Department of Health / CAP College of American Pathologists CD-68 Cluster / Medical Services Advisory Committee / /
Position
pathologist for examination / physician / RT / additional physician / General / messenger / ordering physician / Benefits Scheme MDM Multidisciplinary Meeting mRNA messenger / cellular messenger / candidate for chemotherapy / Governor / Health Minister / pathologist / patient/physician / representative / surgeon / Government Health Minister / /
1342 Consultation Decision Analytical Protocol (DAP) to guide the assessment of gene expression profiling of 21 genes in breast cancer assay to quantify the risk of disease recurrence and predict adjuvant chemotherapy be